View in EDS

CO89 Reductions in Concomitant Medication Use and HbA1c Impact Following Initiation of an Advanced Hybrid Closed-Loop System (AHCL) Versus Multiple Daily Injection (MDI) Therapy in People With Type 2 Diabetes (T2D).

Saved in:
Bibliographic Details
Title: CO89 Reductions in Concomitant Medication Use and HbA1c Impact Following Initiation of an Advanced Hybrid Closed-Loop System (AHCL) Versus Multiple Daily Injection (MDI) Therapy in People With Type 2 Diabetes (T2D).
Authors: Patel, BV1 (AUTHOR), Manjelievskaia, J2 (AUTHOR), Wang, SM1 (AUTHOR), Vaidya, N3 (AUTHOR), Mcdermott, KW2 (AUTHOR), Wall, S2 (AUTHOR), Lavelle, K2 (AUTHOR), Pinsker, JE1 (AUTHOR), Brixner, D4 (AUTHOR), Malone, D4 (AUTHOR)
Source: Value in Health. 2024 Supplement, Vol. 27 Issue 12, pS31-S31. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2024.10.165